MAPT and Alzheimer disease: In tau-associated neurodegenerative diseases (tauopathies), such as Alzheimer’s Disease (AD), tau is abnormally hyperphosphorylated and aggregated into insoluble fibrillary structures, which have been shown to strongly correlate with cognitive decline [30, 33].